Bristol-Myers Squibb Company
4-AZAINDOLE COMPOUNDS
Last updated:
Abstract:
Disclosed are compounds of Formula (I) ##STR00001## N-oxides, or salts thereof, wherein G, A, R.sub.1, R.sub.5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
Status:
Application
Type:
Utility
Filling date:
26 Nov 2019
Issue date:
26 Mar 2020